This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Gilead Sciences, Inc., University of California. Active years: 2020-2022.
Company Filing History:
2 out of 946 
2 out of 15,988 
Years Active: 2020-2022
Title: Michel Joseph Perron: Innovator in Feline Coronavirus Treatments
Introduction
Michel Joseph Perron is a notable inventor based in Morgan Hill, CA (US). He has made significant contributions to the field of veterinary medicine, particularly in the treatment of feline coronavirus infections. With a total of 2 patents, Perron's work has the potential to impact the health and well-being of cats affected by this virus.
Latest Patents
Perron's latest patents focus on innovative methods for treating feline coronavirus infections. These methods utilize carbanucleoside compounds that feature a 1'-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl) substituent, or a pharmaceutically acceptable salt thereof. An exemplary compound described in his patents is (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile. This innovative approach aims to provide effective treatment options for feline coronavirus, which is a significant concern in veterinary medicine.
Career Highlights
Throughout his career, Michel Joseph Perron has worked with prominent organizations such as Gilead Sciences, Inc. and the University of California. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in the treatment of viral infections in felines.
Collaborations
Perron has collaborated with notable professionals in his field, including Niels C Pedersen. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work on feline health.
Conclusion
Michel Joseph Perron is a dedicated inventor whose work in treating feline coronavirus infections showcases his commitment to improving veterinary medicine. His innovative methods and collaborations highlight the importance of research and development in addressing health challenges faced by animals.